| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |